M
Matthew J. Cummings
Researcher at Columbia University
Publications - 35
Citations - 2662
Matthew J. Cummings is an academic researcher from Columbia University. The author has contributed to research in topics: Medicine & Internal medicine. The author has an hindex of 9, co-authored 18 publications receiving 1459 citations. Previous affiliations of Matthew J. Cummings include NewYork–Presbyterian Hospital.
Papers
More filters
Journal ArticleDOI
Epidemiology, clinical course, and outcomes of critically ill adults with COVID-19 in New York City: a prospective cohort study.
Matthew J. Cummings,Matthew R. Baldwin,Darryl Abrams,Samuel D. Jacobson,Benjamin J. Meyer,Elizabeth M. Balough,Justin G. Aaron,Jan Claassen,Le Roy E. Rabbani,Jonathan Hastie,Beth Hochman,John Salazar-Schicchi,Natalie H Yip,Daniel Brodie,Max R. O'Donnell,Max R. O'Donnell +15 more
TL;DR: A prospective observational cohort study on the epidemiology, clinical course, and outcomes of critically ill patients with COVID-19 in New York City and the relation between clinical risk factors, biomarkers, and in-hospital mortality is modelled using Cox proportional hazards regression.
Posted ContentDOI
Epidemiology, clinical course, and outcomes of critically ill adults with COVID-19 in New York City: a prospective cohort study
Matthew J. Cummings,Matthew R. Baldwin,Darryl Abrams,Samuel D. Jacobson,Benjamin J. Meyer,Elizabeth M. Balough,Justin G. Aaron,Jan Claassen,Le Roy E. Rabbani,Jonathan Hastie,Beth Hochman,John Salazar-Schicchi,Natalie H Yip,Daniel Brodie,Max R. O'Donnell,Max R. O'Donnell +15 more
TL;DR: Critical illness among patients hospitalized with COVID-19 in New York City is common and associated with a high frequency of invasive mechanical ventilation, extra-pulmonary organ dysfunction, and substantial in-hospital mortality.
Journal ArticleDOI
Association between antecedent statin use and decreased mortality in hospitalized patients with COVID-19.
Aakriti Gupta,Mahesh V. Madhavan,Timothy J. Poterucha,Ersilia M. DeFilippis,Jessica A. Hennessey,Björn Redfors,Björn Redfors,Christina Eckhardt,Behnood Bikdeli,Behnood Bikdeli,Jonathan Platt,Ani Nalbandian,Pierre Elias,Matthew J. Cummings,Shayan Nabavi Nouri,Matthew Lawlor,Lauren S. Ranard,Jianhua Li,Claudia Boyle,Raymond Givens,Daniel Brodie,Harlan M. Krumholz,Gregg W. Stone,Sanjum S. Sethi,Daniel Burkhoff,Nir Uriel,Allan Schwartz,Martin B. Leon,Ajay J. Kirtane,Elaine Wan,Sahil A. Parikh +30 more
TL;DR: In this article, a multivariable logistic regression model was constructed to predict the propensity of receiving statins, adjusting for baseline sociodemographic and clinical characteristics, and outpatient medications.
Journal ArticleDOI
A randomized double-blind controlled trial of convalescent plasma in adults with severe COVID-19.
Max R. O'Donnell,Beatriz Grinsztejn,Matthew J. Cummings,Jessica Justman,Matthew R. Lamb,Christina M. Eckhardt,Neena M. Philip,Ying Kuen Cheung,Vinay Gupta,Esau Joao,José Henrique Pilotto,Maria Pia Diniz,Sandra W. Cardoso,Darryl Abrams,Kartik N. Rajagopalan,Sarah Borden,Allison Wolf,Leon Claude Sidi,Alexandre Gomes Vizzoni,Valdilea G. Veloso,Zachary C. Bitan,Dawn E. Scotto,Benjamin J. Meyer,Samuel D. Jacobson,Alex Kantor,Nischay Mishra,Lokendra V. Chauhan,Elizabeth F. Stone,Flavia Dei Zotti,Francesca La Carpia,Krystalyn E. Hudson,Stephen A. Ferrara,Joseph E. Schwartz,Brie A. Stotler,Wen-Hsuan W. Lin,Sandeep N. Wontakal,Beth H. Shaz,Thomas Briese,Eldad A. Hod,Steven L. Spitalnik,Andrew Eisenberger,Walter Ian Lipkin +41 more
TL;DR: In a randomized, double-blind, controlled trial among adults hospitalized with severe and critical COVID-19 at 5 sites in New York City (USA) and Rio de Janeiro (Brazil), patients were randomized 2:1 to receive either convalescent plasma or normal control plasma as discussed by the authors.
Posted ContentDOI
A randomized, double-blind, controlled trial of convalescent plasma in adults with severe COVID-19
Max R. O'Donnell,Beatriz Grinsztejn,Matthew J. Cummings,Jessica Justman,Matt Lamb,Christina M. Eckhardt,Neena Phillip,Kenneth Cheung,Darryl Abrams,Vinay Gupta,Maria Pia Diniz,Sandra W. Cardoso,Kartik N. Rajagopalan,Sarah Borden,Allison Wolf,Zachary C. Bitan,Benjamin J. Meyer,Samuel G. Jacobson,Alex Kantor,Nischay Mishra,Eldad A. Hod,Thomas Briese,Leon Claude Sidi,Sandeep N. Wontakal,Krystalyn E. Hudson,Brie A. Stotler,Wen-Hsuan W. Lin,José Henrique Pilotto,Esau Joao,Lokendra V. Chauhan,Valdilea G. Veloso,Joseph E. Schwartz,Elizabeth F. Stone,Flavia Dei Zotti,Francesca La Carpia,Beth H. Shaz,Stephen A. Ferrara,Alexandre Gomes Vizzoni,Steven Spitalnick,Andrew Eisenberger,W. Ian Lipin +40 more
TL;DR: In this paper, the clinical efficacy and safety of convalescent plasma among adults hospitalized with severe and critical COVID-19 was evaluated in a randomized controlled trial conducted from April 21st to November 27th, 2020.